Novo Nordisk clamps down on hiring
Here’s a good-news/bad-news thing for North Carolinians: Novo Nordisk is feeling the effects of increased competition for its popular GLP-1 drugs, Wegovy and Ozempic. The good news in that is downward pressure on prices. The bad news is that downward pressure on prices is translating into downward pressure on profit...
August 22, 2025